A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

Common HIV and cancer medications damage brain cell functions (lipid imbalance), contributing to cognitive decline. Need for ...

Frank Gupton, CEO of Medicines for All, said he hopes that will lead to production facilities closer to those high need areas like sub-Saharan Africa.

In the region, the definition of “high-risk drug use”/“problem drug use” is limited to “current injecting drug use” due to ...

A new report on HIV in Fiji is recommending the set-up of a needle syringe program, to provide sterile needles, as soon as ...

Coalition of charities and MPs have signed a letter from Geordie Greig, editor-in-chief of The Independent, appealing to the ...

A jab against HPV can avert 17.4 deaths for every 1,000 children vaccinated, according to Gavi, meaning the 86m vaccinations will prevent an estimated 1.4m cervical cancer deaths ...

Zimbabwe clears key hurdle for energy project Zimbabwe’s energy sector has reached a major milestone following the successful ...

The governor approved the so-called “Shield Law 2.0,” which bolsters the state's 2023 Trans Safe Haven Act, at a time when ...

Thirty years ago, astronomers weren’t sure planets beyond our solar system even existed. This year, NASA has confirmed its ...

Gilead licensed Assembly Bio's long-acting HSV drugs after Phase 1b data showed antiviral activity and weekly oral dosing potential.